Linjuan Xu
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 4
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 5
- Uterine Myomas and Treatments 3
-
- Extracellular vesicles in disease 3
- Epigenetics and DNA Methylation 2
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 2
- Circular RNAs in diseases 2
- Co-authors
- Zehua WangJing CaiQiang YangYa ZengXiaoqing YiWenhan LiPan LiuHui Ding
- Partner nations
- China
In The Last Decade
Linjuan Xu
17 papers receiving 364 citations
Peers
Comparison fields: 5 of 55
- Reproductive Medicine 61
- Cancer Research 104
- Obstetrics and Gynecology 48
- Immunology 91
- Oncology 115
Countries citing papers authored by Linjuan Xu
This map shows the geographic impact of Linjuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjuan Xu more than expected).
Fields of papers citing papers by Linjuan Xu
This network shows the impact of papers produced by Linjuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjuan Xu. The network helps show where Linjuan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linjuan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2022 | 65 | |
| 7 | 2022 | 25 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 22 | |
| 12 | 2018 | 14 | |
| 13 | 2018 | 28 | |
| 14 | 2015 | 5 | |
| 15 | 2014 | 5 | |
| 16 | 2014 | 47 | |
| 17 | 2013 | 19 | |
| 18 | 2013 | 27 | |
| 19 | 2013 | 24 | |
| 20 | 2012 | 33 |
About Linjuan Xu
Linjuan Xu is a scholar working on Acoustics and Ultrasonics, Obstetrics and Gynecology and Reproductive Medicine, having authored 22 papers that have together received 369 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Extracellular vesicles in disease (3 papers), Uterine Myomas and Treatments (3 papers), Epigenetics and DNA Methylation (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), RNA modifications and cancer (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Reproductive Medicine (61 citations), Cancer Research (104 citations) and Obstetrics and Gynecology (48 citations). Linjuan Xu has collaborated with scholars based in China. Frequent co-authors include Zehua Wang, Jing Cai, Qiang Yang, Ya Zeng, Xiaoqing Yi, Wenhan Li, Pan Liu, Hui Ding, Tao Li and Jing Zhao. Their work appears in journals such as Nature Communications, Oncogene and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.